| Literature DB >> 25246748 |
Wonki Kim1, In Ho Song2, Yong Hoon Lim1, Mi-Ryoung Kim1, Young Eun Kim3, Jae Ha Hwang1, In Keyoung Kim1, Sang Woo Song1, Jin Wook Kim1, Woong-Woo Lee3, Han-Joon Kim3, Cheolyoung Kim4, Hee Chan Kim5, In Young Kim6, Hee Pyoung Park7, Dong Gyu Kim1, Beom Seok Jeon8, Sun Ha Paek9.
Abstract
We investigated the effect of propofol and fentanyl on microelectrode recording (MER) and its clinical applicability during subthalamic nucleus (STN) deep brain stimulation (DBS) surgery. We analyzed 8 patients with Parkinson's disease, underwent bilateral STN DBS with MER. Their left sides were done under awake and then their right sides were done with a continuous infusion of propofol and fentanyl under local anesthesia. The electrode position was evaluated by preoperative MRI and postoperative CT. The clinical outcomes were assessed at six months after surgery. We isolated single unit activities from the left and the right side MERs. There was no significant difference in the mean firing rate between the left side MERs (38.7 ± 16.8 spikes/sec, n=78) and the right side MERs (35.5 ± 17.2 spikes/sec, n=66). The bursting pattern of spikes was more frequently observed in the right STN than in the left STN. All the electrode positions were within the STNs on both sides and the off-time Unified Parkinson's Disease Rating Scale part III scores at six months after surgery decreased by 67% of the preoperative level. In this study, a continuous infusion of propofol and fentanyl did not significantly interfere with the MER signals from the STN. The results of this study suggest that propofol and fentanyl can be used for STN DBS in patients with advanced Parkinson's disease improving the overall experience of the patients.Entities:
Keywords: Deep Brain Stimulation; Fentanyl; Microelectrodes; Parkinson Disease; Propofol; Subthalamic Nucleus
Mesh:
Substances:
Year: 2014 PMID: 25246748 PMCID: PMC4168183 DOI: 10.3346/jkms.2014.29.9.1278
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153